(67 days)
Not Found
No
The summary does not mention AI, ML, or related terms, and the performance studies focus on image quality and reconstruction accuracy compared to predicate devices, not on AI/ML-driven analysis or interpretation.
No
The device is an imaging device used to produce images for diagnostic purposes, not to treat any condition.
Yes
The device is intended to produce images that are "interpreted by healthcare professionals to assess various anatomical structures and functions (e.g., blood flow to the heart)," which is a diagnostic purpose.
No
The device description explicitly lists multiple hardware components including a patient chair, arc with internal rotating slot collimator, lead vanes, CZT detectors, electronic components, power supply, and cooling system.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are medical devices used to examine specimens taken from the human body (like blood, urine, tissue) to provide information about a person's health. This testing is done outside of the body.
- Device Function: The CARDIARC SPECT IMAGING DEVICE is used to produce images of the heart within the patient's body by detecting the distribution of radioisotopes. This is an in vivo imaging technique, not an in vitro diagnostic test.
- Intended Use: The intended use clearly states it's for "production of single photon emission computed tomography clinical images of the heart" and "to produce images from the distribution of radioisotopes within the thorax." This describes an imaging procedure performed on a living patient.
Therefore, the CARDIARC SPECT IMAGING DEVICE falls under the category of medical imaging devices, not In Vitro Diagnostics.
N/A
Intended Use / Indications for Use
The CARDIARC SPECT IMAGING DEVICE and its predicate device is intended to be used for production of single photon emission computed tomography clinical images of the heart in nuclear medicine applications.
The CARDIARC SPECT IMAGING DEVICE is indicated for use to produce images from the distribution of radioisotopes within the thorax, which are then interpreted by healthcare professionals to assess various anatomical structures and functions (e.g., blood flow to the heart).
Product codes
KPS
Device Description
The CARDIARC SPECT IMAGING DEVICE consists of an integrated patient chair which adjusts in height but does not rotate, an arc with no external moving parts, which is constructed of an internal rotating slot collimator, horizontal lead vanes separated by foam spacers, cadmium zinc telluride (CZT) detectors, and electronic components, a power supply, cooling system, and hardware and software components.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
single photon emission computed tomography
Anatomical Site
heart, thorax
Indicated Patient Age Range
Not Found
Intended User / Care Setting
healthcare professionals
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Bench testing was performed using NEMA NU1 phantom or equivalent phantoms, under the NEMA or equivalent standard test procedures. In all cases performance of the CARDIARC SPECT device met or exceeded that of predicate devices.
Cardiac Phantom Imaging was used to test the accuracy of reconstruction and identification of simulated myocardial perfusion defects. Results showed that the quality of reconstructed tomographic images of a test phantom obtained by the CARDIARC SPECT IMAGING DEVICE was at least equal to images obtained by predicate reference SPECT system.
Clinical images were obtained using the CARDIARC SPECT IMAGING DEVICE in human subjects. Tomographic image quality was judged to be excellent by the Board-Certified Nuclear Medicine physicians at the investigational center, and was judged to be at least equal to images obtained by the predicate reference SPECT system.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 892.1200 Emission computed tomography system.
(a)
Identification. An emission computed tomography system is a device intended to detect the location and distribution of gamma ray- and positron-emitting radionuclides in the body and produce cross-sectional images through computer reconstruction of the data. This generic type of device may include signal analysis and display equipment, patient and equipment supports, radionuclide anatomical markers, component parts, and accessories.(b)
Classification. Class II.
0
JAN 6 2006
510(k) SUMMARY
CARDIARC LTD.'s CARDIARC SPECT IMAGING DEVICE
SUBMITTER'S NAME, ADDRESS, TELEPHONE NUMBER, CONTACT PERSON AND DATE PREPARED:
CARDIARC LTD.
8200 Nashville Suite 209 Lubbock, TX 79423
806-722-2027 Phone: Facsimile: 806-722-2029
W. Don Stull, CEO Contact Person: CardiArc, Inc. General Partner
October 27, 2005 Date Prepared:
CARDIARC SPECT IMAGING DEVICE NAME OF DEVICE:
COMMON OR USUAL NAME: SPECT Camera System
CLASSIFICATION NAME: Computed Emission Tomography System
PREDICATE DEVICES:
DIGIRAD 2020tc SPECT Imaging System (K982855)
Segami Corporation Inc.'s Mirage software package (K972886 and K010726)
INTENDED USE / INDICATIONS FOR USE:
The CARDIARC SPECT IMAGING DEVICE and its predicate device is intended to be used for production of single photon emission computed tomography clinical images of the heart in nuclear medicine applications.
The CARDIARC SPECT IMAGING DEVICE is indicated for use to produce images from the distribution of radioisotopes within the thorax, which are then interpreted by healthcare professionals to assess various anatomical structures and functions (e.g., blood flow to the heart).
1
TECHNOLOGICAL CHARACTERISTICS:
The CARDIARC SPECT IMAGING DEVICE consists of an integrated patient chair which adjusts in height but does not rotate, an arc with no external moving parts, which is constructed of an internal rotating slot collimator, horizontal lead vanes separated by foam spacers, cadmium zinc telluride (CZT) detectors, and electronic components, a power supply, cooling system, and hardware and software components.
Thus, the CARDIARC SPECT IMAGING DEVICE raises no new issues of safety or efficacy.
PERFORMANCE DATA:
Bench testing was performed using NEMA NU1 phantom or equivalent phantoms, under the NEMA or equivalent standard test procedures. In all cases performance of the CARDIARC SPECT device met or exceeded that of predicate devices.
Cardiac Phantom Imaging was used to test the accuracy of reconstruction and identification of simulated myocardial perfusion defects. Results showed that the quality of reconstructed tomographic images of a test phantom obtained by the CARDIARC SPECT IMAGING DEVICE was at least equal to images obtained by predicate reference SPECT system.
Clinical images were obtained using the CARDIARC SPECT IMAGING DEVICE in human subjects. Tomographic image quality was judged to be excellent by the Board-Certified Nuclear Medicine physicians at the investigational center, and was judged to be at least equal to images obtained by the predicate reference SPECT system.
SUBSTANTIAL EQUIVALENCE:
The CARDIARC SPECT IMAGING DEVICE has the same intended use, similar principles of operation and technological characteristics as the predicate device. Furthermore, the CARDIARC SPECT IMAGING DEVICE uses predicate device software for image acquisition, processing and display.
Cardiac phantom and clinical imaging demonstrated that the CARDIARC SPECT IMAGING DEVICE produced images at least equal to images obtained with predicate SPECT devices.
2
Image /page/2/Picture/1 description: The image is a seal for the Department of Health & Human Services - USA. The seal is circular and contains the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. In the center of the seal is a stylized image of an eagle.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
CardiArc Ltd. % Mr. Jonathan Kahan Partner Hogan & Hartson L.L.P. 555 Thirteenth Street, NW WASHINGTON DC 20004 Re: K053062
2006
JAN 6
Trade/Device Name: CardiArch Spect Imaging Device Regulation Number: 21 CFR 892.1200 Regulation Name: Emission computed tomography system Regulatory Class: II Product Code: KPS Dated: October 28, 2005 Received: November 3, 2005
Dear Mr. Kahan:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act 's requirements, including, but not limited to registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the clectronic product radiation control provisions (Sections 531-542 of the Act): 21 CFR 1000-1050.
3
This letter will allow you to begin marketing your device as described in your Section 510(k) I his leter will anow you to ough maining of substantial equivalence of your device to a legally premarked notheadon: "The PDF maing" .
marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please If you desire specific acrise to on of the following numbers, based on the regulation number at the top of this letter:
| 21 CFR 876.xxxx | (Gastroenterology/Renal/Urology) | 240-276-0115 | |
|---|---|---|---|
| 21 CFR 884.xxxx | (Obstetrics/Gynecology) | 240-276-0115 | |
| 21 CFR 892.xxxx | (Radiology) | 240-276-0120 | |
| Other | 240-276-0100 |
Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Alloy, prouse note the regulation on your responsibilities under the Act from the 001:377; I od may overs, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Nancy C. Hogdon
Nancy C. Brogdon Director, Division of Reproductive, Abdominal, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Indications for Use
510(k) Number (if known):
Device Name: CARDIARC SPECT IMAGING DEVICE
Indications For Use:
The CARDIARC SPECT IMAGING DEVICE is intended for production of single photon emission computed tomography clinical images of the heart in nuclear medicine applications. CARDIARC SPECT IMAGING DEVICE produces images from the distribution of radioisotopes within the thorax, which are then interpreted by healthcare professionals to assess various anatomical structures and functions (e.g., blood flow to the heart).
Prescription Use (Part 21 CFR 801 Subpart D)
AND/OR
Over-The-Counter Use (21 CFR 807 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
David A. Agnew
(Division Sign-Off) Division of Reproductive, Abdo and Radiological Devices 510(k) Number